[Arsenic: The gold standard for acute promyelocytic leukaemia with FLT3-ITD mutation]

Med Sci (Paris). 2021 May;37(5):544-546. doi: 10.1051/medsci/2021048. Epub 2021 May 18.
[Article in French]
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Arsenic / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute
  • Leukemia, Promyelocytic, Acute / diagnosis*
  • Leukemia, Promyelocytic, Acute / genetics
  • Mutation
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • Antineoplastic Agents
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • Arsenic